Ferriprox (Deferiprone) Patent Expiration, LOE Window & CMS Spending

Ferriprox (Deferiprone) by Chiesi Usa: FDA Orange Book LOE 2028-04-30, 3 AB generics, $13.8M 2024 CMS Part D & Medicaid spend, and 6 CA HCAI SB 17 wholesale price filings.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorChiesi Usa
FDA Application & PathwayN021825 (NDA)
Exclusivity / Cliff HorizonNear-Term Cliff (2028-2030)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity Date2028-04-30
Orange Book Patents (*PED Extensions)0 patents (0 *PED)
Active AB-Rated Generic Competitors3
2024 CMS Total Public Spend$13.8M
2024 Medicare Part D Spend$3.6M
2024 Medicaid Spend$10.2M
Reported Wholesale Price Change (CA SB 17)6 WAC filings (max 21.4% 2-yr change)